The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical activity of ONC201 in metastatic castrate resistant prostate cancer (mCRPC).
 
Mark N. Stein
No Relationships to Disclose
 
Howard Kaufman
Honoraria - Alkermes; Amgen; EMD Serono; Merck; Prometheus; Sanofi Pasteur
Consulting or Advisory Role - Alkermes; Amgen; Merck; Merck Serono; Prometheus
Speakers' Bureau - Merck
Research Funding - Bristol-Myers Squibb/Medarex
Travel, Accommodations, Expenses - Alkermes; EMD Serono; Sanofi
 
Cyril Benes
Speakers' Bureau - AstraZeneca
Research Funding - Amgen; Novartis
 
Martin Stogniew
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
Patents, Royalties, Other Intellectual Property - Oncoceutics
 
Wolfgang Oster
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
 
Joshua E. Allen
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
Patents, Royalties, Other Intellectual Property - Oncoceutics
 
Bruce George Haffty
No Relationships to Disclose
 
Joseph R. Bertino
No Relationships to Disclose